CLOV vs TRS
Clover Health Investments Corp (CLOV) versus TriMas Corporation (TRS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
TriMas Corporation (TRS) is a packaging & containers company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TRS revenue for 2024-12-31 was $925.0M. Net income was $24.3M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. TRS currently screens at market cap $1.53B and trailing P/E 121.8.
CLOV currently screens at market cap $1.55B. TRS currently screens at market cap $1.53B and trailing P/E 121.8.
Not investment advice. Open the CLOV and TRS stock pages for the full models.
Not investment advice.